Skip links

MedTech Europe’s Facts & Figures 2026: Strong Innovation Amid Growing Market Challenges

Europe’s medical technology sector remains a major driver of innovation, economic growth and improvements in healthcare. From advanced medical devices and diagnostic technologies to digital health solutions, the industry continues to develop technologies that support healthcare providers, improve patient outcomes and respond to evolving healthcare needs.

However, despite its strong innovation capacity, the European MedTech sector faces growing challenges related to market growth, global competitiveness and an increasingly complex regulatory environment.

The latest Facts & Figures 2026 report, published by MedTech Europe, provides an overview of the industry’s performance and highlights some of the key trends shaping its future.

A major contributor to Europe’s economy and innovation

The European medical technology industry comprises more than 36,000 companies, approximately 90% of which are small and medium-sized enterprises (SMEs). Together, these companies directly employ more than 950,000 people across Europe, demonstrating the sector’s importance for employment, entrepreneurship and economic development.

Innovation also remains one of the industry’s defining strengths. In 2025, 15,905 medical technology patent applications were filed with the European Patent Office (EPO),. representing a 1.3% increase compared to 2024. Of these applications, 39.7% originated from EPO member states, another 39.7% from the United States, and the remaining 20.6% from other countries.

Innovation remains strong, but market growth is slowing

Despite this innovation activity, recent market indicators suggest that Europe’s medical device sector is experiencing slower growth.

According to MedTech Europe, the European medical device market grew by only 1.8% in 2025, compared with an average annual growth rate of 5.6% over the previous decade.

Europe’s position in the global medical device market has also gradually weakened. Its market share declined from nearly 29% in 2015 to 26.4% in 2024, reaching 25.6% in 2025. By comparison, the United States accounted for 47.6% of the global market in 2025, highlighting the significant gap between the two markets.

Although these figures do not tell the whole story, they raise an important question about Europe’s ability to translate its strong research and innovation performance into medical technologies that successfully reach the market.

For MedTech companies, particularly SMEs, this process involves navigating complex development, clinical evidence and regulatory requirements. While essential for ensuring the safety, quality and performance of medical technologies, these processes also demand considerable resources, expertise and time, making efficient and predictable pathways to market increasingly important.

Towards a more resilient and innovative MedTech ecosystem

In this increasingly complex and ever evolving regulatory landscape, EU4MEDTECH aims to contribute to more effective, evidence-based regulatory processes through the development of its Framework and Digital Platform. By exploring the use of real-world data, AI and closer stakeholder collaboration, the project seeks to support the assessment of MDs and IVDs.

Ultimately, the findings of Facts & Figures 2026 reinforce the importance of these efforts, highlighting Europe’s need to create an environment where innovation can thrive and safe, effective medical technologies can be developed, assessed and made available to those who need them.

Read the full report: MedTech Europe’s Facts & Figures 2026